Table 3 Incidence of first serious morbidity event, death, loss to follow-up and attrition following ART initiation, by time on ART; CMSDS, Abidjan, Côte d’Ivoire, 2003-2008
Duration of follow-up (months) | P ** | ||||
|---|---|---|---|---|---|
0 to 12 | 12 to 72 | ||||
Serious morbidity | |||||
Overall | 10-4 | ||||
Events, n (Time at risk, PY) | 111 | (698) | 81 | (972) | |
Incidence/100 PY (95% CI) | 15.9 | (13.0-18.9) | 8.3 | (6.5-10.2) | |
WHO stage III or IV events | 4.10-3 | ||||
Events, n (Time at risk, PY) | 28 | (734) | 20 | (1214) | |
Incidence/100 PY (95% CI) | 3.8 | (2.4-5.2) | 1.7 | (0.9-2.4) | |
ANRS grade 3 or 4 | 6.10-3 | ||||
Events number (Time at risk, PY) | 26 | (740) | 19 | (1233) | |
Incidence/100 PY (95% CI) | 3.5 | (2.2-4.9) | 1.5 | (0.8-2.2) | |
Confirmed malaria | 0.80 | ||||
Events number (Time at risk, PY) | 24 | (737) | 39 | (1124) | |
Incidence/100 PY (95% CI) | 3.3 | (2.0-4.6) | 3.5 | (2.4-4.6) | |
Other serious events* | 5.10-3 | ||||
Events number (Time at risk, PY) | 22 | (741) | 15 | (1268) | |
Incidence/100 PY (95% CI) | 3.0 | (1.7-4.2) | 1.2 | (0.6-1.8) | |
Death | 10-4 | ||||
Events number (Time at risk, PY) | 32 | (751) | 15 | (1324) | |
Incidence/100 PY (95% CI) | 4.3 | (2.8-5.7) | 1.1 | (0.6-1.7) | |
Lost to follow-up | 10-2 | ||||
Events number (Time at risk, PY) | 61 | (778) | 67 | (1371) | |
Incidence/100 PY (95% CI) | 7.8 | (5.9-9.8) | 4.9 | (3.7-6.1) | |
Attrition | 10-4 | ||||
Events number (Time at risk, PY) | 95 | (769) | 80 | (1369) | |
Incidence/100 PY (95% CI) | 12.4 | (9.9-14.8) | 5.8 | (4.6-7.1) | |